Brazil IVD Market Analysis

Jun 16, 2017
67 Pages - Pub ID: KLI15386111
Share this report
 
Online Download $3,500
Departmental Site License (one location, up to 10 users) $5,250
Global Site License $7,000
Brazil IVD Market Analysis

The Brazilian in vitro diagnostic (IVD) market is ripe for entry. The country has a growing middle class, stabilizing economy, increasing urban population, and a supportive government. The county is witnessing a major shift toward the private health industry, which supports growth of IVD technologies that are expensive or not typically covered at the public level. An increasing interest in molecular testing technologies, prenatal screening, and point-of-care (POC) glucose testing are driving market growth.

Brazil IVD Market Analysis is designed to provide the reader with an overview of the Brazilian laboratory market and its influences. The focus is on the IVD discipline including reagents, consumables, calibrators and controls of the following sub-segments:
  • Clinical Chemistry
  • Immunoassays
  • Microbiology and Molecular Testing
  • Point-of-Care Testing
Increasing incidence of non-communicable disease, a steady incidence of infectious diseases, an increasing disease risk with current lifestyle trends (higher obesity rate, lower activity rates), and other factors have contributed to the current and future Brazil IVD market outlook as outlined in the report:
  • Brazil IVD Sales by Market Segment, 2016-2021 (Clinical Chemistry, Immunoassay, Microbiology/Molecular, POC, Histology, Other, Total)
  • Brazil IVD Sales by Market Segment, 2016 Market Distribution (%) (Clinical Chemistry, Immunoassays, Microbiology/Molecular, POC, Histology, Other)
  • Brazil - Clinical Chemistry Market, 2016-2021
  • Brazil - Immunoassay Market Distribution, 2016-2021 (%) (Infectious Disease, Other, Total Immunoassay)
  • Brazil - Immunoassay Market Value by Segment, 2016 vs. 2021 (Infectious Disease, Other)
  • Brazil - Microbiology/Molecular Testing Market Distribution, 2016-2021 (%) (Infectious Disease, Other, Total Microbiology/Molecular Testing)
  • Brazil Microbiology/Molecular Testing Market Value by Segment, 2016 vs. 2021 (Infectious Disease, Other)
  • POC Market Distribution, 2016-2021 (%) (POC Glucose, POC Infectious Disease, POC Other, Total POC)
  • Brazil POC Market Value by Segment, 2016 vs. 2021 (POC Glucose, POC Infectious Disease, Others)
  • Brazil - Histology Market, 2016-2021
Included in Brazil IVD Market Analysis are trends influencing the industry and country-level data including incidence of disease, life expectancy, population demographics, economic status, healthcare utilization and other market influences.

The IVD market is highly competitive worldwide and Latin America is no exception. Brazil's IVD market is dominated by a handful of global competitors, which are profiled in the report:
  • Abbott Laboratories
  • Alere
  • Becton, Dickinson and Company
  • bioMérieux SA
  • Danaher Corporation
  • Roche (F. Hoffman-La Roche, Ltd.)
  • Siemens Healthineers
  • Sysmex Corporation
The information in Brazil IVD Market Analysis was gathered using both primary and secondary research methods including more than 25 interviews completed during the period of April 2017 and June 2017. These interviews were with government officials, medical device regulators, Brazilian-based distributors, health care providers and leading market participants. In some cases, the use of a third-party interpreter service was used to complete the interview. Secondary data included the use of government databases, company literature, medical journals and reports.
CHAPTER 1: EXECUTIVE SUMMARY
INDUSTRY OVERVIEW
SCOPE AND METHODOLOGY
BRAZIL IVD MARKET SUMMARY
Figure 1-1: Brazil In Vitro Diagnostic Sales by Market Segment, 2016-2021 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other)
CHAPTER 2: BRAZIL OVERVIEW
POPULATION
Table 2-1: Total Midyear Population by Broad Age Group: Brazil (million persons), 2010-2050 (0-14, 15-64, 65+)
Figure 2-1: Total Midyear Population by Broad Age Group: Brazil (million persons), 2010-2050 (0-14, 15-64, 65+)
Figure 2-2: Total Number of Births in Brazil by Year, 1970-2010, and Forecast 2020-2050
Figure 2-3: Brazil Life Expectancy at Birth in Years, 2010-2050
Population Urbanization
ECONOMY AND HEALTH SPENDING
Figure 2-4: Brazil GDP, GDP (PPP) and Health Spending, 1990-2015
Figure 2-5: Brazil Distribution of Income or Consumption by Quintile, 1990-2014
CHAPTER 3: THE HEALTH SYSTEM IN BRAZIL
HEALTH INFRASTRUCTURE
Figure 3-1: Brazilian Coverage Rate (%) for Private Health Plans and Public Health Plans, 2003-2015 (Private Medical Aid Plan Beneficiaries with or without Dental Care, Public Health Plan Beneficiaries)
Figure 3-2: Health Expenditures, Public vs. Private as a % of Total Health Expenditures, 2015 (Private, Public)
Medical Facilities
Figure 3-3: Distribution of JCI Accredited Facilities by Metropolitan Area (%) (Sao Paulo, Rio de Janeiro, Recife, Brasilia, Porto Alegre, Others)
Figure 3-4: Distribution of JCI Accredited Facilities by Type (%) (Hospital Program, Academic Medical Center, Ambulatory Care, Home Care, Medical Transport, Primary Care)
Figure 3-5: Hospital Bed Density per 1,000 Population by Country, 2016 Estimates (US, UK, Singapore, Japan, Germany, China, Canada, Brazil, Australia)
Physicians and Health Professionals
Figure 3-6: Physician Density per 1,000 Population by Country, 2016 Estimates (US, UK, Singapore, Japan, Germany, China, Canada, Brazil, Australia)
Figure 3-7: Nurse/Midwife Density per 1,000 Population by Country, 2016 Estimates (US, UK, Singapore, Japan, Germany, China, Canada, Brazil, Australia)
The Brazilian Diagnostic Laboratory Environment
Figure 3-8: Laboratories and Collection Sites in Brazil by Type (%), 2016 (Collection Sites, all types; Commercial Laboratories; Hospital-based Laboratories)
Figure 3-9: Distribution of Volume, Brazil's Leading Clinical Laboratory Service Providers (%), 2016
Medical Device Regulation
Table 3-1: Market Divers and Inhibitors for Entering Brazil's Medical Device Market
Figure 3-10: Market Entry Complexity for Foreign Operators in Brazil
Brazil's Growing Medical Tourism Industry
HEALTH INDICATORS
General Health
Disease Profiles in Brazil
Table 3-2: Top 5 Cancers Affecting Brazilian Population (ranked by total number of cases), 2010-2016 (Male, Female, Total [both sexes])
Figure 3-11: Highly Prevalent Medical Conditions/Diseases in Brazil (Zika virus, Tuberculosis, Malaria, Leprosy, HIV, Diabetes, Dengue, Chagas disease, Cardiovascular diseases, Cancer)
Surgical Procedures in Brazil
Table 3-3: Surgical Procedures in Brazil as Compared to Rest of Latin America (%) (Cardiovascular procedures, Digestive/Gastrointestinal procedures, Obstetrical/Gynecological procedures, Orthopedic procedures, ENT/Respiratory procedures, Urinary surgical procedures, Cosmetic/Aesthetic procedures, Other procedures, Total)
Figure 3-12: Brazil, Mexico and Rest of LATAM Distribution of Population Compared to Surgical Procedures (%)
CHAPTER 4: IVD MARKETS IN BRAZIL
BRAZIL IVD MARKET SUMMARY
Table 4-1: Brazil In Vitro Diagnostic Sales by Market Segment, 2016-2021 (Clinical Chemistry, Immunoassay, Microbiology/Molecular, POC, Histology, Other, Total)
Figure 4-1: Brazil In Vitro Diagnostic Sales by Market Segment, 2016-2021 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other)
Figure 4-2: Brazil In Vitro Diagnostic Sales by Market Segment, 2016 Market Distribution (%) (Clinical Chemistry, Immunoassays, Microbiology/Molecular, POC, Histology, Other)
CLINICAL CHEMISTRY
Figure 4-3: Brazil - Clinical Chemistry Market, 2016-2021
IMMUNOASSAY
Table 4-2: Brazil - Immunoassay Market Distribution, 2016-2021 (%) (Infectious Disease, Other, Total Immunoassay)
Figure 4-4: Brazil - Immunoassay Market Value by Segment, 2016 vs. 2021 (Infectious Disease, Other)
MICROBIOLOGY/MOLECULAR
Table 4-3: Brazil - Microbiology/Molecular Testing Market Distribution, 2016-2021 (%) (Infectious Disease, Other, Total Microbiology/Molecular Testing)
Figure 4-5: Brazil Microbiology/Molecular Testing Market Value by Segment, 2016 vs. 2021 (Infectious Disease, Other)
POINT-OF-CARE
Table 4-4: Brazil - POC Market Distribution, 2016-2021 (%) (POC Glucose, POC Infectious Disease, POC Other, Total POC)
Figure 4-6: Brazil POC Market Value by Segment, 2016 vs. 2021 (POC Glucose, POC Infectious Disease, Others)
HISTOLOGY
Figure 4-7: Brazil - Histology Market, 2016-2021
CHAPTER 5: COMPETITIVE ANALYSIS AND PROFILES
COMPETITIVE SUMMARY
Table 5-1: Leading IVD Market Suppliers in Brazil, Market Share Percentage, 2016
Figure 5-1: Leading IVD Market Suppliers in Brazil, 2016 (%)
ABBOTT LABORATORIES
Table 5-2: Abbott Laboratories Company Summary
Company Overview
Company Performance
Product Summary
ALERE
Table 5-3: Alere Company Summary
Company Overview
Performance Review
Product Summary
BECTON, DICKINSON AND COMPANY
Table 5-4: Becton, Dickinson and Company Summary
Company Overview
Company Performance
Product Summary
BIOMÉRIEUX SA
Table 5-5: bioMerieux Summary
Company Overview
Company Performance
Product Summary
DANAHER CORPORATION
Table 5-6: Danaher Corporation Summary
Company Overview
Company Performance
Product Summary
ROCHE (F. HOFFMAN-LA ROCHE, LTD.)
Table 5-7: Roche Group Summary
Company Overview
Company Performance
Product Summary
SIEMENS HEALTHINEERS
Table 5-8: Siemens Healthineers Company Summary
Company Overview
Company Performance
Product Summary
SYSMEX CORPORATION
Table 5-9: Sysmex Corporation Summary
Company Overview
Company Performance
Product Summary
APPENDIX: SOURCES OF INFORMATION

In this report, {{keyword[keywordTextProperty]}} appears {{keyword[keywordCountProperty]}} times. {{searchResults.STATRESULT.SUMMARY.KW[keywordTextProperty]}} appears {{searchResults.STATRESULT.SUMMARY.KW[keywordCountProperty]}} times.

We were unable to search inside this report.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.